Meghan Ross, Associate Editor

The FDA today approved peramivir injection, an IV neuraminidase inhibitor intended to treat acute uncomplicated influenza in patients 18 or older who have been symptomatic for no more than 2 days.

A Tampa-based pharmacist could face a maximum of 20 years in federal prison after a jury found him guilty of conspiracy to distribute and dispense oxycodone.

A new FDA-approved drug could help treat complicated intra-abdominal infections and complicated urinary tract infections among adults.

A total of 65% of patients polled rate pharmacists as having very high or high standards of ethics and honesty.

Product contains 3 new drugs that work to inhibit the growth of HCV.

The FDA today approved ombitasvir, paritaprevir, and ritonavir tablets copackaged with dasabuvir tablets to treat individuals with chronic hepatitis C virus genotype 1 infection, including patients with cirrhosis.

The majority of fatal poisonings in 2012 resulted from prescription drug use.

A mother in the United Kingdom started to worry about her 13-month-old daughter when she noticed Mollie staring straight ahead in the car and not responding to her name.

A new FDA approval may soon help children with allergies seek relief from nasal symptoms.

Pharmacists tied medical doctors for second place in Gallup's latest honesty and ethics poll.

Treatment shows promising anti-tumor activity.

A new study from researchers in Japan has identified features that appear to be responsible for bacteria becoming resistant to antibiotics.

A cheery vintage advertisement depicting kids playing in a yard promotes "cocaine toothache drops" sold at an Albany, New York, pharmacy in March 1885.

Extroverted workers should keep an eye out for introverts in the workplace.

Methamphetamine users are about 3 times more likely to develop Parkinson's disease than individuals who do not abuse the illegal drug.

Two cofounders of a Massachusetts compounding pharmacy, plus 12 other former employees, have been arrested for allegedly distributing tainted drugs that caused a fungal meningitis outbreak in 2012, killing 64 individuals.

An Ohio pharmacist is facing 46 counts related to health care fraud, after her plans to defraud Medicare, Medicaid, the Ohio Bureau of Workers' Compensation, and private insurers were discovered.

A new test cleared by the FDA will help determine a patient's risk of coronary heart disease events, such as a heart attack.

New research posits that cocaine use quadruples the risk of sudden cardiovascular death among individuals aged 19 to 49 years.

In a head-to-head phase 3b study, Novartis' secukinumab (Cosentyx) beat Janssen Pharmaceuticals' ustekinumab (Stelara) in clearing the skin of patients with psoriasis.

An Australian pharmacist was caught distributing addictive drugs, falsifying entries to disguise his theft of pills, and supplying medications without prescriptions.

The growth rate for pharmacists is 14% by 2022.

More information will be garnered from Human T-cell Lymphotropic Virus-I/II screenings, thanks to a new FDA approval.

A Maine pharmacy tech has pleaded guilty to stealing drugs and falsifying records, after he was caught on camera taking handfuls of pills.

Contrary to the "mean girl" stereotype, adolescent male students manifest more relationally aggressive behavior than girls, according to new research from the University of Georgia.

Merck's anti"PD-1 therapy Keytruda has demonstrated an overall response rate of 18.5% among patients with PD-L1 positive, advanced triple-negative breast cancer, one of the most aggressive forms of breast cancer.

Medication shows promising results in phase 3 study.

A concerned Minnesota Department of Transportation employee noticed something was off when she saw a man slumped over in his truck on the side of the road.

Celgene Corporation's study results of romidepsin in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of patients with peripheral T-cell lymphoma showed 51% of patients achieved a complete response, according to a Celgene press release.

Study shows patients with high baseline bleed rate can benefit from treatment.